Ligand Pharmaceuticals Inc. (LGND) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for LGND. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 402 institutions reported holding LGND, with 22.6 million shares worth $7.1 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 3,100,996 | $980M | INCREASED |
| Vanguard | 2,186,410 | $691M | INCREASED |
| Invesco Ltd | 1,201,644 | $380M | INCREASED |
| Janus Henderson (Jupiter Topco) | 1,040,578 | $329M | INCREASED |
| State Street | 826,539 | $261M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Jason Aryeh (Director) | SELL | 282 | $90K | 2026-11-04 |
| Jason Aryeh (Director) | SELL | 700 | $224K | 2026-11-02 |
| Andrew Reardon (CLO & Secretary) | EXERCISE | 5,000 | $261K | 2026-11-02 |
| Andrew Reardon (CLO & Secretary) | SELL | 120 | $39K | 2026-11-02 |
| Andrew Reardon (CLO & Secretary) | SELL | 200 | $64K | 2026-11-02 |
Full institutional holdings, insider history, and congressional trades for Ligand Pharmaceuticals Inc. on SentiSense.